Bigul

RAJKAMAL SYNTHETICS LTD. - 514028 - Board Meeting Outcome for Board Meeting Outcome For Standalone Un-Audited Financial Result For Quarter Ended June 30, 2022 Alongwith Limited Review Report

1. Considered and approved the Standalone Unaudited Financial Result (with Limited Review) of the Company for the quarter year ended 30th June, 2022 pursuant to Regulation 33 of the SEBI Listing Regulations. 2. Resignation of Ms. Jaya Jain, Company Secretary and Compliance Officer of the Company with effect from August 13, 2022.
13-08-2022
Bigul

RAJKAMAL SYNTHETICS LTD. - 514028 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results (With Limited Review) Of The Company For The Quarter Ended June 30, 2022

RAJKAMAL SYNTHETICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 ,inter alia, to consider and approve Standalone Unaudited Financial Results (with Limited Review) of the Company for the quarter ended June 30, 2022
05-08-2022
Bigul

RAJKAMAL SYNTHETICS LTD. - 514028 - Statement Of Investor Complaints For The Quarter Ended June 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- ANKUR AJMERADesignation :- Managing Director / Whole Time Director
18-07-2022
Bigul

RAJKAMAL SYNTHETICS LTD. - 514028 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Enclosed herewith the certificate confirming compliance under Reg.74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended June 30, 2022
18-07-2022
Bigul

RAJKAMAL SYNTHETICS LTD. - 514028 - Revised Financials For The Financial Year Ended March 31, 2022.

Revised financials for the financial year ended March 31, 2022.
28-06-2022
Bigul

RAJKAMAL SYNTHETICS LTD. - 514028 - Financial Results For The Financial Year Ended March 31, 2022

In terms of Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, enclosed is the Audited Standalone financial year ended March 31, 2022 alongwith Statutory Auditor''s Report
30-05-2022
Bigul

RAJKAMAL SYNTHETICS LTD. - 514028 - Financial Results For Quarter Ended March 31, 2022

In terms of Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, enclosed is the Audited Standalone Financial Results for the quarter ended March 31, 2022 alongwith Statutory Auditor''s Report.
30-05-2022
Bigul

RAJKAMAL SYNTHETICS LTD. - 514028 - Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On May 30, 2022

This is to inform you that the Board of Directors of the Company, in its meeting held today, viz. Monday, May 30, 2022 have considered and approved following business: 1) Audited Standalone Financial Results for the quarter ended March 31, 2022. 2) Audited Standalone Financial Statement along with the Auditors Report of the Company for the financial year ended March 31, 2022 including Balance sheet, Statement of Profit and Loss & Cash Flow Statement. We are enclosing herewith the financial results for your information and records. We request you to take the above on record and treat the same as a disclosure under Regulation 30 of the SEBI Listing Regulations, read with SEBI circular CIR/CFD/CMD/4/2015, dated 9th September, 2015, and/or such other applicable Regulation(s) of the SEBI Listing Regulations.
30-05-2022
Bigul

RAJKAMAL SYNTHETICS LTD. - 514028 - Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On May 30, 2022

This is to inform you that the Board of Directors of the Company, in its meeting held today, viz. Monday, May 30, 2022 have considered and approved following business: 1) Audited Standalone Financial Results for the quarter ended March 31, 2022. 2) Audited Standalone Financial Statement along with the Auditors Report of the Company for the financial year ended March 31, 2022 including Balance sheet, Statement of Profit and Loss & Cash Flow Statement. We are enclosing herewith the financial results for your information and records. We request you to take the above on record and treat the same as a disclosure under Regulation 30 of the SEBI Listing Regulations, read with SEBI circular CIR/CFD/CMD/4/2015, dated 9th September, 2015, and/or such other applicable Regulation(s) of the SEBI Listing Regulations.
30-05-2022
Next Page
Close

Let's Open Free Demat Account